Zdrowie i gospodarka · 22/08/2011

FDA Postpones Arthritis Advisory Committee Meeting

The FDA is postponing the Arthritis Advisory Committee meeting originally scheduled for September 13, 2011, due to new information from IND application holders for anti-nerve growth factor antibody drug products. This decision was announced in the Federal Register on July 19, 2011.